EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter outcomes-based evaluation of the Vitros Immunodiagnostic products Anti-HCV reagent pack and calibrator in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection



Multicenter outcomes-based evaluation of the Vitros Immunodiagnostic products Anti-HCV reagent pack and calibrator in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection



Hepatology 34(4 Pt 2): 231A, October




(PDF 0-2 workdays service: $29.90)

Accession: 035349861

Download citation: RISBibTeXText



Related references

Multicenter evaluation of the Vitros Immunodiagnostic products HBsAg reagent pack and calibrator and the Vitros Immunodiagnostic products HBsAg Confirmatory Kit in patients with signs and symptoms of hepatitis or at risk for viral hepatitis. Clinical Chemistry 47(S6): A99, June, 2001

Multicenter outcomes-based evaluation of the Vitros Immunodiagnostic products anti-HBs reagent pack and calibrators in immunized patients and patients with signs and symptoms of hepatitis. Clinical Chemistry 47(S6): A98-A99, June, 2001

Multicenter evaluation of the VITROS Anti-HBs assay in immunized patients and patients with signs and symptoms of hepatitis. Hepatology 32(4 Pt 2): 578A, October, 2000

Evaluation of office-based intervention to improve prevention counseling for patients at risk for sexually acquired hepatitis B virus infection. Hepatitis B-WARE Study Group. American Journal of Obstetrics and Gynecology 182(1 Pt 1): 1-6, 2000

Predicting Outcomes of Patients With Chronic Hepatitis B Virus Infection Based on Quantification of the Hepatitis B Surface Antigen. Clinical Gastroenterology and Hepatology 14(10): 1499-1501, 2016

Clinical, virologic, and histologic implications of GBV-C/HGV infection in patients with chronic hepatitis C virus infection A multicenter study based on 671 patients. Hepatology 26(4 PART 2): 435A, 1997

Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. Journal of Viral Hepatitis 16(12): 860-866, 2010

Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission. American Journal of Gastroenterology 97(9): 2426-2431, September, 2002

Search for hepatitis delta virus (HDV) infection in hepatitis C patients in northeastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B. European Journal of Epidemiology 18(6): 559-561, 2003

Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients. Canadian Journal of Infectious Diseases & Medical Microbiology 26(6): 293-296, 2016

Diagnosis of acute hepatitis b virus infection by detection of anti hepatitis b core immuno globulin m in hepatitis b surface antigen negative patients. Liver 2(3 PART 2): 312, 1982

Prevalence and risk factors of hepatitis C virus infection in hospitalized diabetic patients Results of a prospective multicenter study in 1561 consecutive patients. Hepatology 28(4 PART 2): 469A, 1998

Performance of three hepatitis markers on the Ortho Vitros ECi Immunodiagnostic System. Clinical Chemistry 48(6 Supplement): A65, June, 2002